SUNNYVALE, Calif. , July 17, 2014 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today that its CyberKnife ® and TomoTherapy ® Systems have received the highest composite overall user satisfaction rating among radiation treatment delivery systems in the U.S., according to the Q2 2014
Installation at Burdenko Institute of Neurosurgery will be Accuray's Second in Russia SUNNYVALE, Calif., Aug. 7 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that the Burdenko Institute of Neurosurgery in Moscow has
Acquisition Marks First Robotic Radiosurgery System in Russia, Expanding Patients' Cancer Treatment Options SUNNYVALE, Calif., Nov. 19 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that the N. N.
SUNNYVALE, Calif., Oct. 26 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that the company is partnering with The University of Texas M. D. Anderson Cancer Center in Houston, Texas to launch a prospective clinical study
Provides personalized care to treat the full spectrum of radiation oncology patients SUNNYVALE, Calif. , Dec. 19, 2011 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that 23 leading medical centers globally have installed both a
Patients Benefit from Fewer Treatment Sessions and Minimal Side Effects SUNNYVALE, Calif. , March 31, 2016 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that MedStar Georgetown University Hospital in Washington, D.C. treated its 1,000th prostate cancer patient with the
- One-of-a-kind Accuray Radixact® and CyberKnife® Systems Offer Technological Innovations Designed to Deliver Unique Patient Benefits - Mercy is First in Missouri to Acquire the Radixact and CyberKnife M6™ Systems SUNNYVALE, Calif. , May 9, 2018 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY)
Day 1 Experience Demonstrates the Speed and Efficiency of the New System SUNNYVALE, Calif. , Jan. 26, 2017 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that Miami Cancer Institute , a part of Baptist Health South Florida, is now treating patients using the new, uniquely
SUNNYVALE, Calif. , Aug. 23, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today the appointment of Mika Nishimura to the company's Board of Directors, effective as of August 17, 2021 . With Ms. Nishimura's appointment, the Accuray Board will consist of nine members. Ms.
Cutting-Edge Radiation Therapy System Dramatically Improves Precision, Efficiency and Safety, While Minimizing Side Effects SUNNYVALE, Calif. and NEW YORK , June 27, 2017 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) and Montefiore Einstein Center for Cancer Care (MECCC), part of the
*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.